Colorectal cancer in middle-aged women in relation to hormonal status: A report from the Women's Health in the Lund Area (WHILA) study.
(2006) In Gynecological Endocrinology 22(8). p.416-422- Abstract
- Objective. To delineate a perceived association of estradiol versus estradiol plus norethisterone hormone therapy on the prevalence of colorectal cancer in postmenopausal women.
Methods. The Women's Health in the Lund Area (WHILA) project covers 10 766 women aged 50-60 years, living in the Lund area, Sweden. Out of this population, 6908 (64%) women completed questionnaires, underwent physical and laboratory assessments and had self-reported information regarding colorectal cancer. Four hundred and twenty-two (6%) were premenopausal (PM), 3600 (52%) were postmenopausal without hormone therapy (PM0), 2452 (36%) were postmenopausal with combined hormone therapy (PMT-HT) and 364 (5%) were postmenopausal with estrogen... (More) - Objective. To delineate a perceived association of estradiol versus estradiol plus norethisterone hormone therapy on the prevalence of colorectal cancer in postmenopausal women.
Methods. The Women's Health in the Lund Area (WHILA) project covers 10 766 women aged 50-60 years, living in the Lund area, Sweden. Out of this population, 6908 (64%) women completed questionnaires, underwent physical and laboratory assessments and had self-reported information regarding colorectal cancer. Four hundred and twenty-two (6%) were premenopausal (PM), 3600 (52%) were postmenopausal without hormone therapy (PM0), 2452 (36%) were postmenopausal with combined hormone therapy (PMT-HT) and 364 (5%) were postmenopausal with estrogen monotherapy (PMT-E).
Results. There were 21 cases of colorectal cancer (0.3%), one in the PM group, 16 in the PM0 group, two in the PMT-HT group and another two in the PMT-E group. Colorectal cancer prevalence was lower in the PMT-HT than in the PM0 group (odds ratio (OR) = 0.18, 95% confidence interval (CI) = 0.04-0.80). However, for the PMT-E group, the OR (95% CI) was 1.02 (0.86-1.20). There was a positive association between low physical activity (p = 0.04), low parity (p = 0.02) and risk of colorectal cancer.
Conclusion. Combined hormone therapy seemed to be associated with a lower risk of colorectal cancer in postmenopausal women in contrast to estrogen monotherapy. Hence the progestin might have a protective role. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/162476
- author
- Nazeri, Kavoos LU ; Khatibi Esfanjani, Ali LU ; Nyberg, Per LU ; Agardh, Carl-David LU ; Lidfeldt, Jonas LU and Samsioe, Göran LU
- organization
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Colorectal cancer, middle-aged women, hormone therapy, estrogen monotherapy, progesterone
- in
- Gynecological Endocrinology
- volume
- 22
- issue
- 8
- pages
- 416 - 422
- publisher
- Informa Healthcare
- external identifiers
-
- wos:000241899300002
- scopus:33749458428
- ISSN
- 0951-3590
- DOI
- 10.1080/09513590600900378
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division of Nursing (Closed 2012) (013065000), Family Medicine (013241010), Pediatrics/Urology/Gynecology/Endocrinology (013240400), Department of Clinical Sciences, Lund (013230000), Emergency medicine/Medicine/Surgery (013240200), Unit on Vascular Diabetic Complications (013241510), Department of Obstetrics and Gynaecology (Lund) (013018000)
- id
- a393b73c-ce62-40e4-9e91-1d450a3506dc (old id 162476)
- date added to LUP
- 2016-04-01 12:12:17
- date last changed
- 2022-01-27 00:21:53
@article{a393b73c-ce62-40e4-9e91-1d450a3506dc,
abstract = {{Objective. To delineate a perceived association of estradiol versus estradiol plus norethisterone hormone therapy on the prevalence of colorectal cancer in postmenopausal women.<br/><br>
<br/><br>
Methods. The Women's Health in the Lund Area (WHILA) project covers 10 766 women aged 50-60 years, living in the Lund area, Sweden. Out of this population, 6908 (64%) women completed questionnaires, underwent physical and laboratory assessments and had self-reported information regarding colorectal cancer. Four hundred and twenty-two (6%) were premenopausal (PM), 3600 (52%) were postmenopausal without hormone therapy (PM0), 2452 (36%) were postmenopausal with combined hormone therapy (PMT-HT) and 364 (5%) were postmenopausal with estrogen monotherapy (PMT-E).<br/><br>
<br/><br>
Results. There were 21 cases of colorectal cancer (0.3%), one in the PM group, 16 in the PM0 group, two in the PMT-HT group and another two in the PMT-E group. Colorectal cancer prevalence was lower in the PMT-HT than in the PM0 group (odds ratio (OR) = 0.18, 95% confidence interval (CI) = 0.04-0.80). However, for the PMT-E group, the OR (95% CI) was 1.02 (0.86-1.20). There was a positive association between low physical activity (p = 0.04), low parity (p = 0.02) and risk of colorectal cancer.<br/><br>
<br/><br>
Conclusion. Combined hormone therapy seemed to be associated with a lower risk of colorectal cancer in postmenopausal women in contrast to estrogen monotherapy. Hence the progestin might have a protective role.}},
author = {{Nazeri, Kavoos and Khatibi Esfanjani, Ali and Nyberg, Per and Agardh, Carl-David and Lidfeldt, Jonas and Samsioe, Göran}},
issn = {{0951-3590}},
keywords = {{Colorectal cancer; middle-aged women; hormone therapy; estrogen monotherapy; progesterone}},
language = {{eng}},
number = {{8}},
pages = {{416--422}},
publisher = {{Informa Healthcare}},
series = {{Gynecological Endocrinology}},
title = {{Colorectal cancer in middle-aged women in relation to hormonal status: A report from the Women's Health in the Lund Area (WHILA) study.}},
url = {{http://dx.doi.org/10.1080/09513590600900378}},
doi = {{10.1080/09513590600900378}},
volume = {{22}},
year = {{2006}},
}